Clinical Lung CancerSCIE

文章摘录

• Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical Resection Author: Yu, Lian; Xu, Jianlin; Qiao, Rong; Han, Baohui; Zhong, Hua; Zhong, Runbo Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 1, pp. e1-e8. DOI: 10.1016/j.cllc.2022.08.006
• The comparison of Lobe-Specific or Systematic Mediastinal Lymph Node Dissection for Early-Stage Lung Adenocarcinoma With Consolidation Tumor Ratio Over 0.5 Author: Sui, Qihai; Yang, Huiqiang; Yin, Jiacheng; Li, Ming; Jin, Xing; Chen, Zhencong; Jiang, Wei; Wang, Qun Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 1, pp. 51-59. DOI: 10.1016/j.cllc.2022.08.005
• The Value of Radiotherapy in Patients With Resectable Stage IIIA Non-Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis Author: Liu, Bohao; Wang, Zhiyu; Zhao, Heng; Gao, Shan; Wang, Hongyi; Zhang, Yanpeng; Fan, Kun; Tao, Runyi; Li, Yixing; Feng, Jinteng; Sun, Yuchen; Zhang, Jia; Zhang, Guangjian Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 1, pp. 18-28. DOI: 10.1016/j.cllc.2022.09.011
• Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy Author: Fu, Jing; Tong, Yuyang; Xu, Ziguang; Li, Yaonan; Zhao, Ya; Wang, Tao; Li, Cuidan; Cang, Shundong Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 1, pp. 29-39. DOI: 10.1016/j.cllc.2022.08.007
• Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study Author: Li, Huiying; Zheng, Shengnan; Lin, Yongjuan; Yu, Tingting; Xie, Yu; Jiang, Cheng; Liu, Xiangyu; Qian, Xiaoping; Yin, Zhenyu Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 2, pp. E94-E104. DOI: 10.1016/j.cllc.2022.11.011
• Epidemiological and Therapeutic Analyses in Lung Cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database Study Author: Koizumi, Tomonobu; Nishino, Yoshikazu; Takiguchi, Tomoya; Kanda, Shintaro; Otsuki, Kengo; Tanaka, Yuriko; Tomita, Reiji; Araki, Taisuke; Hayashi, Ryuji; Yasumoto, Kazuo; Uramoto, Hidetaka; Hirono, Yasuo; Makino, Tomoe; Nakada, Mitsutoshi; Yano, Seiji Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 2, pp. 145-152. DOI: 10.1016/j.cllc.2022.12.001
• The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation Author: Dieleman, Edith; van der Woude, Lisa; van Os, Rob; van Bockel, Liselotte; Coremans, Ida; van Es, Corine; De Jaeger, Katrien; Knol, Hans Peter; Kolff, Willemijn; Koppe, Frederike; Pomp, Jacqueline; Reymen, Bart; Schinagl, Dominic; Spoelstra, Femke; Tissing-Tan, Caroline; van Zyp, Noelle van der Voort; van der Wel, Antoinet; Wijsman, Robin; Dielwart, Michel; Wiegman, Erwin; Damhuis, Ronald; Belderbos, Jose Journal: CLINICAL LUNG CANCER. 2023; Vol. 24, Issue 2, pp. 130-136. DOI: 10.1016/j.cllc.2022.11.008
• A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib Author: You-cai Zhu, Wen-xian Wang, Chun-wei Xu, Wu Zhuang, Kai-qi Du, Gang Chen, Tang-feng Lv, Yong Song Journal: Clinical Lung Cancer, 2019, Vol., , DOI:10.1016/j.cllc.2019.02.020